9/28/23 16:39 | 9/28/23 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 319 | 15.96 | 0 | 20 | 26 | 97 | D | | | | | | | | | | | | | | |
9/14/23 19:33 | 9/13/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.dm | 43 | 2.94 | 0 | 15 | 4 | 383 | D | | | | | | | | | | | | | | |
9/14/23 19:33 | 9/13/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.dm | -467 | 32.00 | 0 | -15 | -4 | 383 | D | | | | | | | | | | | | | | |
6/9/23 16:20 | 6/8/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 43 | 2.94 | 0 | 15 | 4 | 383 | D | | | | | | | | | | | | | | |
6/9/23 16:20 | 6/8/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -424 | 29.00 | 0 | -15 | -4 | 383 | D | | | | | | | | | | | | | | |
5/4/23 21:58 | 5/3/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 43 | 2.94 | 0 | 15 | 4 | 383 | D | | | | | | | | | | | | | | |
5/4/23 21:58 | 5/3/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -409 | 28.00 | 0 | -15 | -4 | 383 | D | | | | | | | | | | | | | | |
5/2/23 19:17 | 4/28/23 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 0 | 4 | 5 | 77 | D | | | | | | | | | | | | | | |
9/2/22 17:10 | 8/31/22 | RPHM | Reneo Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | DO | Exec CB | M.d | 99 | 1.97 | 0 | 50 | 9 | 629 | D | | | | | | | | | | | | | | |
5/2/22 18:06 | 4/29/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 0 | 4 | 7 | 65 | I | | | | | | | | | | | | | | |
7/23/21 17:00 | 7/22/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 12 | 2.37 | 0 | 5 | 9 | 62 | D | | | | | | | | | | | | | | |
7/23/21 17:00 | 7/22/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | S.d | -500 | 100.04 | 0 | -5 | -7 | 62 | D | | | | | | | | | | | | | | |
4/30/21 18:58 | 4/30/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 0 | 11 | 19 | 70 | I | | | | | | | | | | | | | | |
4/13/21 18:03 | 4/12/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 36 | 2.37 | 0 | 15 | 32 | 62 | D | | | | | | | | | | | | | | |
4/13/21 18:03 | 4/12/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | S.d | -1,354 | 90.28 | 0 | -15 | -19 | 62 | D | | | | | | | | | | | | | | |
3/9/21 17:59 | 3/5/21 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 132 | 26.49 | 0 | 5 | 13 | 43 | D | | | | | | | | | | | | | | |
3/9/21 17:59 | 3/5/21 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -381 | 76.28 | 0 | -5 | -10 | 43 | D | | | | | | | | | | | | | | |
12/16/20 17:36 | 12/14/20 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 184 | 16.84 | 0 | 11 | | 4 | D | | | | | | | | | | | | | | |
12/16/20 17:36 | 12/14/20 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -2,675 | 245.45 | 0 | -11 | -72 | 4 | D | | | | | | | | | | | | | | |
8/7/20 17:40 | 8/5/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 7 | 3.95 | 0 | 2 | 3 | 62 | D | | | | | | | | | | | | | | |
8/7/20 17:40 | 8/5/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | S.d | -129 | 73.35 | 0 | -2 | -3 | 62 | D | | | | | | | | | | | | | | |
8/5/20 18:56 | 8/3/20 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 66 | 26.49 | 0 | 3 | 6 | 43 | D | | | | | | | | | | | | | | |
8/5/20 18:56 | 8/3/20 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -301 | 120.35 | 0 | -3 | -6 | 43 | D | | | | | | | | | | | | | | |
7/22/20 17:33 | 7/22/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 7 | 3.95 | 0 | 2 | 3 | 62 | D | | | | | | | | | | | | | | |
7/22/20 17:33 | 7/22/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | S.d | -105 | 60.00 | 0 | -2 | -3 | 62 | D | | | | | | | | | | | | | | |
6/26/20 17:00 | 6/25/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 7 | 3.95 | 0 | 2 | 3 | 62 | D | | | | | | | | | | | | | | |
6/26/20 17:00 | 6/25/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | S.d | -97 | 55.00 | 0 | -2 | -3 | 62 | D | | | | | | | | | | | | | | |
5/26/20 17:00 | 5/22/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 83 | 7.84 | 0 | 11 | 20 | 62 | D | | | | | | | | | | | | | | |
5/26/20 17:00 | 5/22/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | S.d | -514 | 48.77 | 0 | -11 | -14 | 62 | D | | | | | | | | | | | | | | |
5/4/20 17:29 | 5/2/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 0 | 15 | 33 | 62 | I | | | | | | | | | | | | | | |
11/14/19 18:30 | 11/12/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 59 | 16.84 | 0 | 4 | | 2 | D | | | | | | | | | | | | | | |
11/14/19 18:30 | 11/12/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -312 | 102.44 | 0 | -3 | -57 | 2 | D | | | | | | | | | | | | | | |
8/14/19 19:30 | 8/12/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 59 | 16.84 | 0 | 4 | | 2 | D | | | | | | | | | | | | | | |
8/14/19 19:30 | 8/12/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -281 | 92.27 | 0 | -3 | -63 | 2 | D | | | | | | | | | | | | | | |
5/15/19 19:00 | 5/13/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 120 | 16.84 | 0 | 7 | | 1 | D | | | | | | | | | | | | | | |
5/15/19 19:00 | 5/13/19 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -376 | 65.30 | 0 | -6 | -81 | 1 | D | | | | | | | | | | | | | | |
5/6/19 17:49 | 5/3/19 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 0 | 15 | 49 | 47 | I | | | | | | | | | | | | | | |
5/7/18 17:05 | 5/3/18 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 0 | 14 | 65 | 36 | I | | | | | | | | | | | | | | |
5/10/17 19:22 | 5/10/17 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | P | 95 | 9.48 | 33 | 10 | 65 | 25 | I | -64 | -35 | -34 | -40 | -31 | -35 | -36 | -35 | 7 | | | | | |
5/4/17 17:59 | 5/3/17 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 33 | 14 | 933 | 15 | I | -49 | -1 | -10 | -8 | 4 | 0 | -1 | -2 | 2 | -37 | | | | |
5/10/16 16:40 | 5/6/16 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | L2 | D | | M.d | 0 | 0.00 | 33 | 5 | New | 5 | I | 16 | -45 | -12 | -5 | -4 | 6 | -1 | 4 | -5 | 1 | 25 | 41 | 2 | |
2/23/16 16:41 | 2/22/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 289 | 38.59 | 33 | 8 | 40 | 26 | D | -2 | -27 | -39 | -27 | -18 | 4 | 17 | 1 | 1 | 8 | 10 | 14 | 21 | 19 |
2/23/16 16:41 | 2/22/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -600 | 80.00 | 33 | -8 | -22 | 26 | D | -2 | -27 | -39 | -27 | -18 | 4 | 17 | 1 | 1 | 8 | 10 | 14 | 21 | 19 |
11/18/15 16:49 | 11/16/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 289 | 38.59 | 33 | 8 | 40 | 26 | D | 55 | 29 | -16 | -21 | 5 | -6 | -7 | 0 | -4 | -9 | -7 | -28 | -21 | -17 |
11/18/15 16:49 | 11/16/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -782 | 104.27 | 33 | -8 | -22 | 26 | D | 55 | 29 | -16 | -21 | 5 | -6 | -7 | 0 | -4 | -9 | -7 | -28 | -21 | -17 |
12/13/13 18:07 | 12/11/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 651 | 21.71 | 33 | 30 | | 23 | D | 103 | 36 | 17 | -4 | 8 | -4 | -3 | -3 | 0 | -2 | 3 | 13 | -13 | 32 |
12/13/13 18:07 | 12/11/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -2,090 | 69.66 | 33 | -30 | -57 | 23 | D | 103 | 36 | 17 | -4 | 8 | -4 | -3 | -3 | 0 | -2 | 3 | 13 | -13 | 32 |
3/8/13 17:40 | 3/3/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 216 | 14.39 | 33 | 15 | 323 | 20 | D | 154 | 79 | 65 | 28 | 13 | 12 | 10 | 2 | -1 | 2 | 1 | -4 | 15 | 26 |
3/8/13 17:40 | 3/6/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -909 | 60.61 | 33 | -15 | -43 | 20 | D | 154 | 79 | 65 | 28 | 13 | 12 | 10 | 2 | -1 | 2 | 1 | -4 | 15 | 26 |
2/24/12 19:02 | 2/23/12 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 508 | 16.92 | 33 | 30 | | 16 | D | 76 | 44 | 27 | 13 | -3 | -5 | -7 | -3 | 4 | 2 | -2 | 9 | 8 | 59 |
3/7/08 12:51 | 3/5/08 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S | -134 | 38.41 | 33 | -4 | -41 | 5 | D | 192 | 128 | 66 | 40 | 3 | -8 | -2 | -2 | -4 | -7 | -3 | 4 | -23 | -73 |
3/7/08 12:45 | 3/5/08 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | M.d | 310 | 10.33 | 33 | 30 | | 9 | D | 192 | 128 | 66 | 40 | 3 | -8 | -2 | -2 | -4 | -7 | -3 | 4 | -23 | -73 |
3/7/08 12:45 | 3/5/08 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Grey Michael G | CA | D | | S.d | -821 | 38.17 | 33 | -22 | -72 | 9 | D | 192 | 128 | 66 | 40 | 3 | -8 | -2 | -2 | -4 | -7 | -3 | 4 | -23 | -73 |